| Name | Title | Contact Details |
|---|
Blueprint Medicines is developing a new generation of highly selective and potent kinase therapies to dramatically improve the lives of patients with genomically defined diseases. Our approach is rooted in a deep understanding of the genetic blueprint of cancer and other diseases driven by the abnormal activation of kinases. Our ability to identify novel drivers of disease, coupled with our proprietary library of novel and diverse chemical compounds, uniquely enables us to craft kinase therapies against new and difficult-to-drug targets. We are boldly advancing a deep pipeline of highly targeted therapies against previously unaddressed drivers of disease. By focusing on genomically defined subsets of patients, we believe we can identify the people most likely to respond to our therapies, resulting in a more efficient clinical development path with a greater likelihood of success and better outcomes for patients. We see a substantial opportunity in kinase drug discovery and development to deliver breakthrough medicines that allow patients to live longer with better quality of life and prevent recurrences of disease. Kinases are involved in many hallmarks of tumor biology and are proven cancer drug targets. Currently approved drugs focus on less than 5 percent of known kinases, and the function of most kinases is unknown. Led by a team of industry innovators with a track record of bringing life-changing drugs to market, we believe Blueprint Medicines has the experience and expertise to deliver on the tremendous untapped potential of kinase therapies to improve patients’ lives. We don’t think in small steps. We think in giant leaps. We are driven by the pursuit of new ideas, new innovations, and new ways of thinking.
Advance Driving Systems Inc is a Tallahassee, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Corexcel is a Wilmington, DE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
We are the nation`s largest veterinary partner-pharmacy providing veterinarians with a custom online store so they can offer the best home delivery service for their clients. We offer pet owners a way to shop online with their own veterinarian in a safe and secure web store for their pet. Behind the scenes, we are the veterinarian`s fully-licensed and accredited veterinary pharmacy. We have direct partnerships with all of the manufacturers--so we don`t just guarantee that the products “are the same”...we 100% guarantee that all products have been handled properly to maintain their quality. That`s a big difference when it comes to the safety of a pet.
Tapinator (Ticker: TAPM) is a global developer and publisher of mobile games on the iOS, Google Play, and Amazon platforms. The Company focuses on operating its own titles, publishing properties where it holds substantial ownership positions, and making strategic investments into promising mobile companies. Tapinator’s owned and operated portfolio includes over 55 mobile gaming titles that, collectively, have over 30 million users. A number of these titles have risen to the top of the mobile leaderboard charts and have been featured by the Apple, Google, and Amazon App Stores. Founded in 2013, Tapinator is headquartered in New York, with development offices in Pakistan, Denmark and Indonesia.